Loading…
Lobbying Spend
—
Filings
54
Firms Hired
1
Active Period
2001–2017
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
2017 · fourth_quarter · Firm: ERNST & YOUNG LLP (WASHINGTON COUNCIL ERNST & YOUNG)
H.R. 1 - Tax reform - proposals related to repatriation
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1
FDA Reauthorization Act of 2017
2017 · second_quarter · Firm: ERNST & YOUNG LLP (WASHINGTON COUNCIL ERNST & YOUNG)
General healthcare and budget issues; access to medical device issues, HR 2430 - FDA reauthorization act
Client expense: — · Firm income: $60,000
Matched citations: HR 2430
21st Century Cures Act
2016 · fourth_quarter · Firm: ERNST & YOUNG LLP (WASHINGTON COUNCIL ERNST & YOUNG)
General healthcare and budget issues; general domestic and international tax issues; access to medical device issues. S 1767 - Combination Product Regulatory Fairness Act of 2016. Health care reimbursement issues. 21st Century Cures legislation (HR 6/HR 34)
Client expense: — · Firm income: $60,000
Matched citations: HR 34
21st Century Cures Act
2016 · fourth_quarter · Firm: ERNST & YOUNG LLP (WASHINGTON COUNCIL ERNST & YOUNG)
General healthcare and budget issues; general domestic and international tax issues; access to medical device issues. S 1767 - Combination Product Regulatory Fairness Act of 2016. Health care reimbursement issues. 21st Century Cures legislation (HR 6/HR 34)
Client expense: — · Firm income: $60,000
Matched citations: HR 6
Combination Product Regulatory Fairness Act of 2016
2016 · fourth_quarter · Firm: ERNST & YOUNG LLP (WASHINGTON COUNCIL ERNST & YOUNG)
General healthcare and budget issues; general domestic and international tax issues; access to medical device issues. S 1767 - Combination Product Regulatory Fairness Act of 2016. Health care reimbursement issues. 21st Century Cures legislation (HR 6/HR 34)
Client expense: — · Firm income: $60,000
Matched citations: S 1767
Combination Product Regulatory Fairness Act of 2016
2016 · third_quarter · Firm: ERNST & YOUNG LLP (WASHINGTON COUNCIL ERNST & YOUNG)
General healthcare and budget issues; general domestic and international tax issues; access to medical device issues. S 1767 - Combination Product Regulatory Fairness Act of 2016. Health care reimbursement issues.
Client expense: — · Firm income: $60,000
Matched citations: S 1767
Combination Product Regulatory Fairness Act of 2016
2016 · second_quarter · Firm: ERNST & YOUNG LLP (WASHINGTON COUNCIL ERNST & YOUNG)
General healthcare and budget issues; general domestic and international tax issues; access to medical device issues. S 1767 - Combination Product Regulatory Fairness Act of 2016.
Client expense: — · Firm income: $60,000
Matched citations: S 1767
Medicare CGM Access Act of 2014
2014 · fourth_quarter · Firm: ERNST & YOUNG LLP (WASHINGTON COUNCIL ERNST & YOUNG)
General healthcare and budget issues; General domestic and intl. tax issues; Access to medical device issues; S. 2689 (Collins); S. 2917 (Harkin); H.R. 83 (FY 2015 CR/Omnibus).
Client expense: — · Firm income: $60,000
Matched citations: S. 2689
Adding Ebola to the FDA Priority Review Voucher Program Act
2014 · fourth_quarter · Firm: ERNST & YOUNG LLP (WASHINGTON COUNCIL ERNST & YOUNG)
General healthcare and budget issues; General domestic and intl. tax issues; Access to medical device issues; S. 2689 (Collins); S. 2917 (Harkin); H.R. 83 (FY 2015 CR/Omnibus).
Client expense: — · Firm income: $60,000
Matched citations: S. 2917
Protecting Access to Medicare Act of 2014
2014 · third_quarter · Firm: ERNST & YOUNG LLP (WASHINGTON COUNCIL ERNST & YOUNG)
General healthcare issues; Access to medication issues; Drug pricing issues; Prescription drug benefit issues. Draft legislation on physician payment reform. HR 4302, Protecting Access to Medicare Act, Clinical diagnostic lab test payment reform.
Client expense: — · Firm income: $60,000
Matched citations: HR 4302
Protecting Access to Medicare Act of 2014
2014 · second_quarter · Firm: ERNST & YOUNG LLP (WASHINGTON COUNCIL ERNST & YOUNG)
General healthcare issues; General domestic and intl. tax issues; Access to medication issues; Drug pricing issues; Prescription drug benefit issues. Draft legislation on physician payment reform. HR 4302, Protecting Access to Medicare Act, Clinical diagnostic lab test payment reform.
Client expense: — · Firm income: $60,000
Matched citations: HR 4302
Protecting Access to Medicare Act of 2014
2014 · first_quarter · Firm: ERNST & YOUNG LLP (WASHINGTON COUNCIL ERNST & YOUNG)
General healthcare issues; General domestic and intl. tax issues; Access to medication issues; Drug pricing issues; Prescription drug benefit issues. Draft legislation on physician payment reform. HR 4302, Protecting Access to Medicare Act, Clinical diagnostic lab test payment reform.
Client expense: — · Firm income: $60,000
Matched citations: HR 4302
Source: Senate LDA